Merit Medical Systems, Inc. Forecast, price target & analysts
Merit Medical Systems, Inc. Target price 2025 - Analyst rating & recommendation
Merit Medical Systems, Inc. Classifications & Recommendation:
Merit Medical Systems, Inc. Price Target
| Target Price | $118.20 |
| Price | $98.50 |
| Potential |
20.00%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Merit Medical Systems, Inc. 2026 .
The average Merit Medical Systems, Inc. target price is $118.20.
This is
20.00%
register free of charge
$128.00
29.95%
register free of charge
$111.00
12.69%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend Merit Medical Systems, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Merit Medical Systems, Inc. stock has an average upside potential 2026 of
20.00%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.35 | 1.48 |
| 8.07% | 9.29% | |
| EBITDA Margin | 20.02% | 23.41% |
| 12.42% | 16.92% | |
| Net Margin | 8.80% | 9.50% |
| 15.96% | 7.90% |
10 Analysts have issued a sales forecast Merit Medical Systems, Inc. 2025 . The average Merit Medical Systems, Inc. sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Merit Medical Systems, Inc. EBITDA forecast 2025. The average Merit Medical Systems, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Merit Medical Systems, Inc. Analysts have issued a net profit forecast 2025. The average Merit Medical Systems, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.03 | 2.39 |
| 25.31% | 17.73% | |
| P/E | 41.16 | |
| EV/Sales | 4.20 |
6 Analysts have issued a Merit Medical Systems, Inc. forecast for earnings per share. The average Merit Medical Systems, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Merit Medical Systems, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Merit Medical Systems, Inc....
Current Merit Medical Systems, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham | Locked ➜ Locked | Locked | Feb 26 2025 |
| Canaccord Genuity | Locked ➜ Locked | Locked | Feb 26 2025 |
| Wells Fargo | Locked ➜ Locked | Locked | Feb 26 2025 |
| Barrington Research | Locked ➜ Locked | Locked | Feb 26 2025 |
| Piper Sandler | Locked ➜ Locked | Locked | Jan 29 2025 |
| Canaccord Genuity | Locked ➜ Locked | Locked | Jan 29 2025 |
| Needham | Locked ➜ Locked | Locked | Jan 29 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham: Locked ➜ Locked
|
Feb 26 2025 |
|
Locked
Canaccord Genuity: Locked ➜ Locked
|
Feb 26 2025 |
|
Locked
Wells Fargo: Locked ➜ Locked
|
Feb 26 2025 |
|
Locked
Barrington Research: Locked ➜ Locked
|
Feb 26 2025 |
|
Locked
Piper Sandler: Locked ➜ Locked
|
Jan 29 2025 |
|
Locked
Canaccord Genuity: Locked ➜ Locked
|
Jan 29 2025 |
|
Locked
Needham: Locked ➜ Locked
|
Jan 29 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
